Search

Your search keyword '"Institut de cancérologie de l'Ouest - Nantes (ICO Nantes)"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Institut de cancérologie de l'Ouest - Nantes (ICO Nantes)" Remove constraint Author: "Institut de cancérologie de l'Ouest - Nantes (ICO Nantes)"
35 results on '"Institut de cancérologie de l'Ouest - Nantes (ICO Nantes)"'

Search Results

1. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

2. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment

3. microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation

4. Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer

5. Cell Tracking in Cancer Immunotherapy

6. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode

7. Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations

8. Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells

9. Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

10. 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study

11. Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines:mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx

12. Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study

13. Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

14. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

15. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity

16. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma

17. Logic programming reveals alteration of key transcription factors in multiple myeloma

18. Pharmacological targeting of apelin impairs glioblastoma growth

19. Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18 F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

20. Ionizing radiation induces long-term senescence in endothelial cells through mitochondrial respiratory complex II dysfunction and superoxide generation

21. Report of the 6th International Workshop on PET in lymphoma

22. Voxel-based multi-model fitting method for modelling time activity curves in SPECT images

23. E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death

24. New advances in DPYD genotype and risk of severe toxicity under capecitabine

25. Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

26. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients

27. TestDose: A nuclear medicine software based on Monte Carlo modeling for generating gamma camera acquisitions and dosimetry

28. Apelin, the Devil Inside Brain Tumors

29. Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan

30. Classification of current anticancer immunotherapies

31. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study

32. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients

33. Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study

34. Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial

35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for first relapse of ovarian cancer

Catalog

Books, media, physical & digital resources